therascreen PIK3CA RGQ PCR Kit

FDA Premarket Approval P190001 S001

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Changes to in-process qc testing

Devicetherascreen PIK3CA RGQ PCR Kit
Generic NameSomatic Gene Mutation Detection System
ApplicantQIAGEN GMBH
Date Received2020-03-04
Decision Date2020-04-03
PMAP190001
SupplementS001
Product CodeOWD 
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address QIAGEN GMBH qiagen Strasse 1 hilden 40724

Supplemental Filings

Supplement NumberDateSupplement Type
P190001Original Filing
S001 2020-03-04 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.